Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

835 résultats trouvés

Genes involved in APP-mediated GLUT1 regulation

Alzheimer’s disease is the most common form of dementia.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2024

Brain Health Resources and Integrated Diversity (BRAID) Hub

The BRAID Hub (Brain health Resources And Integrated Diversity Hub) addresses critical gaps in Canada’s dementia care system.


Domaine de recherche
Neurodégénérescence
Province
Ontario
DATE DE DÉBUT
2024

Assessing the Efficacy of a Hypomethylating Agent to Decrease Post-Pneumonia Cognitive Impairments

Infections like pneumonia can speed up dementia. Vaccinations can prevent infections but don’t always work in older adults.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Ontario
DATE DE DÉBUT
2024

Boosting self-cueing to maintain independence in dementia

Everyday activities such as cooking often become difficult for people living with dementia.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Ontario
DATE DE DÉBUT
2024

A physiologic-to-tissue level approach to characterize the pathophysiology of hypoxic ischemic brain injury in humans.

During a cardiac arrest, when the heart stops beating, blood flow and the delivery of the oxygen to the brain stops.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Blessures
Concours
Les futurs leaders de la recherche sur le cerveau au Canada
Province
Colombie-Britannique
DATE DE DÉBUT
2024

Amyloid beta oligomers: refining the therapeutic target through photolabelling and fractionation

We know that Alzheimer’s disease is caused by the clumping together of misfolded proteins in the brain, specifically two proteins called amyloid beta and tau.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Alberta
DATE DE DÉBUT
2024

Does psilocybin increase synaptic density in the brain in patients with mild cognitive impairment?

Amnestic mild cognitive impairment (aMCI) is viewed as a precursor to Alzheimer’s Disease (AD) for which there are no effective treatments.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Ontario
DATE DE DÉBUT
2024

Investigating a putative modifier of HTT toxicity using cellular assays


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Concours
Société Huntington du Canada - Bourse Brain Canada pour étudiants de premier cycle
Province
Colombie-Britannique
DATE DE DÉBUT
2024

Targeting the microbiota-gut-brain axis with diet and exercise interventions in individuals with subjective cognitivedecline

Individuals with or at increased risk of Alzheimer’s disease (AD) have an altered community of microbes(microbiome) within the intestinal tract.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
DATE DE DÉBUT
2024

Deciphering the link between gut bacteria and glymphatics in neurodegeneration

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease in humans.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Alberta
DATE DE DÉBUT
2024